Glenmark Pharmaceuticals
GLENMARK.NS
#2749
Rank
ยฃ3.53 B
Marketcap
ยฃ12.51
Share price
0.59%
Change (1 day)
25.58%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): ยฃ0.09994

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is ยฃ0.08250. In 2022 the company made an earnings per share (EPS) of ยฃ0.29 a decrease over its 2021 EPS that were of ยฃ0.37.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.09994-65.81%
2022ยฃ0.29-20.18%
2021ยฃ0.377.13%
2020ยฃ0.3425.72%
2019ยฃ0.27-22.01%
2018ยฃ0.3530.15%
2017ยฃ0.27-34.82%
2016ยฃ0.4163.09%
2015ยฃ0.259.68%
2014ยฃ0.23-26.58%
2013ยฃ0.310.51%
2012ยฃ0.31